4-[4-(4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-5-yl]-N-(2-methoxy-6-methyl-4-pyridinyl)pyrimidin-2-amine
C25H25FN6OS — CID 155541728
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-(4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-5-yl]-N-(2-methoxy-6-methyl-4-pyridinyl)pyrimidin-2-amine
4-[4-(4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-5-yl]-N-(2-methoxy-6-methyl-4-pyridinyl)pyrimidin-2-amine (PubChem CID 155541728) has the molecular formula C25H25FN6OS and a molecular weight of 476.58 g/mol. Its IUPAC name is 4-[4-(4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-5-yl]-N-(2-methoxy-6-methyl-4-pyridinyl)pyrimidin-2-amine.
Molecular Properties
| Compound Name | 4-[4-(4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-5-yl]-N-(2-methoxy-6-methyl-4-pyridinyl)pyrimidin-2-amine |
|---|---|
| PubChem CID | 155541728 |
| Molecular Formula | C25H25FN6OS |
| Molecular Weight | 476.58 g/mol |
| Exact Mass | 476.18 |
| IUPAC Name | 4-[4-(4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-5-yl]-N-(2-methoxy-6-methyl-4-pyridinyl)pyrimidin-2-amine |
| SMILES | COc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)cc(C)n1 |
| InChI | InChI=1S/C25H25FN6OS/c1-15-13-19(14-21(29-15)33-2)30-25-28-12-9-20(31-25)23-22(16-3-5-18(26)6-4-16)32-24(34-23)17-7-10-27-11-8-17/h3-6,9,12-14,17,27H,7-8,10-11H2,1-2H3,(H,28,29,30,31) |
| InChIKey | DKNIAUBHOPFIKK-UHFFFAOYSA-N |
| XLogP | 5.33 |
| TPSA | 84.85 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.58 |
| LogP ≤ 5 | 5.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155541728 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.